Stocks Comparison
Cadre vs Edwards Lifesciences: revenue, profit, margins and growth compared
Cadre brought in $610.3M of revenue in fiscal 2025, Edwards Lifesciences $6.1B in fiscal 2025. Revenue changed by +7.5% at Cadre and +11.5% at Edwards Lifesciences on the year before, so Edwards Lifesciences grew faster. Cadre kept 7.2% of its revenue as net profit, Edwards Lifesciences 17.7%. Free cash flow was $56.8M at Cadre and $1.3B at Edwards Lifesciences.
Side by side, latest fiscal year
| CDRE | EW | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $610.3M | $6.1B |
| Revenue growth | +7.5% | +11.5% |
| Net income | $44.1M | $1.1B |
| Net margin | 7.2% | 17.7% |
| Free cash flow | $56.8M | $1.3B |
| Free cash flow margin | 9.3% | 22.0% |
| Earnings per share (diluted) | $1.02 | $1.83 |
| Cash | $122.9M | $2.9B |
| Debt | $307.3M | $598.3M |
| Price to earnings | 25.9 | 47.1 |
| Market value | $1.1B | $49.7B |
| Dividend yield | 0.36% | n/a |
| Rank by revenue in sector | #179 of 523 · Health care | #54 of 523 · Health care |
Over the years
Questions about Cadre and Edwards Lifesciences
Which is bigger by revenue, Cadre or Edwards Lifesciences?
Edwards Lifesciences is bigger by revenue: $6.1B in fiscal 2025, against $610.3M for Cadre in fiscal 2025.
Which keeps more of its revenue as profit, Cadre or Edwards Lifesciences?
Cadre had a net margin of 7.2% in fiscal 2025; Edwards Lifesciences had 17.7% in fiscal 2025.
Which grew revenue faster, Cadre or Edwards Lifesciences?
In their latest fiscal years revenue changed by +7.5% at Cadre and +11.5% at Edwards Lifesciences.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.